Directory
>
David Chang
David Chang
President and Chief Executive Officer | Allogene Therapeutics
United States
David Chang
Summary
David Chang is a visionary leader in the biotechnology industry, currently serving as the President and CEO of Allogene Therapeutics. With a robust background in medical oncology and a passion for advancing cancer treatments, he has been instrumental in developing groundbreaking therapies. His previous role as Chief Medical Officer at Kite Pharma saw him play a pivotal part in the FDA approval of the first CAR T therapy for non-Hodgkin lymphoma. David's academic credentials are impressive, with degrees from prestigious institutions like MIT and Stanford, and he has received numerous awards for his contributions to cancer research. He is committed to innovation in medicine and believes that the best scientific advancements are still ahead. Outside of his professional endeavors, David is known for mentoring young scientists and fostering collaboration between academia and industry.
David Chang
Work Experience
President and Chief Executive Officer at
Allogene Therapeutics
April 2018 - Present
Executive Vice President, R&D, Chief Medical Officer at
Kite Pharma
June 2014 - March 2018
Vice President of Global Development and Head of Hematology-Oncology at
Amgen, Inc.
June 2006 - May 2014
David Chang
Education
Dana-Farber Cancer Institute , Fellowship
January 1992 - January 1994
Brigham and Women's Hospital, Internship And Residency
January 1990 - January 1992
Massachusetts Institute of Technology, Damon-Runyon Postdoctoral Fellow (Advisor: Phillip A. Sharp, Phd)
January 1988 - January 1990
Stanford University, Md/Phd, Nih Mstp Trainee (Advisor: David A. Clayton, Phd)
January 1981 - January 1988
Massachusetts Institute of Technology, Bs
January 1978 - January 1981
Frequently Asked Questions about David Chang
What is David Chang email address?
David Chang's primary email address is ******@allogene.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does David Chang work for?
David Chang is a President and Chief Executive Officer at Allogene Therapeutics, a company specializing in Biological products, except diagnostic.
Where David Chang graduated from?
David Chang holds a degree in Medical Oncology Residency Program from Dana-Farber Cancer Institute .
How can I directly contact David Chang?
To contact David Chang directly, you can use the email address ******@allogene.com. Complete contact information is available upon registration with Muraena.
Who is David Chang?
David Chang is a visionary leader in the biotechnology industry, currently serving as the President and CEO of Allogene Therapeutics. With a robust background in medical oncology and a passion for advancing cancer treatments, he has been instrumental in developing groundbreaking therapies. His previous role as Chief Medical Officer at Kite Pharma saw him play a pivotal part in the FDA approval of the first CAR T therapy for non-Hodgkin lymphoma. David's academic credentials are impressive, with degrees from prestigious institutions like MIT and Stanford, and he has received numerous awards for his contributions to cancer research. He is committed to innovation in medicine and believes that the best scientific advancements are still ahead. Outside of his professional endeavors, David is known for mentoring young scientists and fostering collaboration between academia and industry.
David`s contact details
******@allogene.com
Colleagues
Vice President, Translational Sciences
VP GxP Quality and Compliance
Executive Director, Corporate Strategy and Business Insights
Member Board Of Directors
Vice President, Corporate Counsel
Executive Director Information Technology
Executive Director, Head of IP
Executive Director of Biology, Solid Tumors
Executive Director, Head of Bioinformatics
Vice President, Product Development and Manufacturing